Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
26 May 2020 Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX‑CoV2373, a stable, prefusion…
Read MoreAustralia’s top scientists elected as Fellows of the Academy
25 May 2020 An Australian scientist who identified the cause of mass frog extinctions across the globe is among a group of scientists being acknowledged today for their outstanding contributions to science. Associate Professor Lee Berger’s research into…
Read MoreMatchmaking platform to boost local manufacturing supply chains
19 May 2020 Via the Hon Karen Andrews MP, Minister for Health Australian businesses wanting to play their part in the response to the COVID-19 pandemic will have greater access to potential partners and customers thanks to an…
Read MoreCloud-based bioinformatics platform fast-tracking genomic analysis
21 May 2020 Researchers at the University of Melbourne Centre for Cancer Research (UMCCR) have established a reliable, scalable and fast bioinformatics platform to analyse the genomic data of hundreds of cancer patients. This new cloud-computing based platform…
Read MoreCOVID-19 prevention trial opens for high risk healthcare workers
20 May 2020 The first gold standard Australian clinical trial to determine whether the drug hydroxychloroquine can prevent COVID-19 is now open. The study, called COVID SHIELD, will recruit frontline and allied health care professionals, aiming to reduce…
Read More$400 million funding boost for health and medical research
20 May 2020 The Morrison Government will invest almost $400 million in world-leading health and medical research projects to improve the lives of all Australians. Our Government will strengthen Australians’ health through research to prevent illness and deliver…
Read MoreVivaZome and Cytiva enter into an agreement on downstream technology for exosome purification
21 May 2020 VivaZome Therapeutics Pty Ltd (“VivaZome”) and Cytiva, formerly part of GE Healthcare Life Sciences, have entered into an agreement where Cytiva’s range of purification technologies, including Fibro, will be applied to VivaZome’s selected exosome fractions,…
Read MoreIsrael becomes first Middle Eastern market for Sienna’s hTERT IVD
21 May 2020 Sienna Cancer Diagnostics Ltd is pleased to announce the appointment of Zotal Ltd (“Zotal”) as its exclusive distributor in Israel. The distribution agreement provides Zotal with the right to sell Sienna’s hTERT IVD to pathology…
Read MoreMCRI launches landmark study into children’s COVID-19 immune responses with assistance from Rio Tinto
19 May 2020 The Murdoch Children’s Research Institute (MCRI) has launched its COVID Immune research program to investigate COVID-19 effects on children’s immune systems. The new program, an Australian first, has been made possible with support from Rio Tinto,…
Read More$32 million for the next generation of clinician researchers to pursue critical health and medical research
20 May 2020 The Australian Government will invest almost $32 million through the Medical Research Future Fund (MRFF) in world-leading health and medical research projects. 30 early- to mid-career researchers will be offered 5-year grants funded through the…
Read MoreFDA allows Veyonda® Pre-IND Submission for COVID-19
19 May 2020 Noxopharm (ASX:NOX) today announces that on advice from the U.S. Food and Drug Administration (FDA), the Company has lodged a pre-Investigational New Drug (pre-IND) submission for a clinical trial of Veyonda® in patients with SARS-CoV-2…
Read MoreSupporting Victorian Universities
19 May 2020 The Victorian Government will make an unprecedented investment in local universities to protect jobs and support the state’s economic rebound from the coronavirus crisis. Minister for Training and Skills and Higher Education Gayle Tierney joined…
Read More
